Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
The snakebite antivenin CroFab, on the U.S. market since 2000, now faces competition from a drug called Anavip. But both are expensive. "Perverse incentives" keep prices high, says one legal scholar.
Read more on NPR
August 8, 2019 at 04:00PM
Health Care
NPR News: Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment
Posted by Unknown |
16:09
Related Posts:
NPR News: Sturgill Simpson On World CafeSturgill Simpson On World Cafe Hear the Americana star perform songs from A Sailor's Guide To Earth and discuss writing for his son in this session. … Read More
Diverse Looks in the Indian Capital By Unknown Author from NYT Fashion & Style http://ift.tt/2dUudve via IFTTT … Read More
NPR News: Technology May Rescue Male Baby Chicks From The GrinderTechnology May Rescue Male Baby Chicks From The Grinder The egg industry may soon eliminate a wasteful – and to some, horrifying – practice: Slaughter… Read More
Distinctly New Delhi By THE NEW YORK TIMES from NYT Fashion & Style http://ift.tt/2fofsWI via IFTTT … Read More
NPR News: Listen: World Cafe's Hip-For-Halloween PlaylistListen: World Cafe's Hip-For-Halloween Playlist Had enough of "Monster Mash", "Time Warp" and "Thriller"? Get in the Halloween spirit with these alter… Read More
0 nhận xét:
Đăng nhận xét